AbbVie Stock Will $300: Timing and Risks to Watch
AbbVie’s Q1 2026 results show strong immunology growth even as biosimilar challenges weigh on revenue. Analysts debat...
Both hold potential in different domains: Bitcoin as peer-to-peer money and blockchain as a platform for diverse, programmable applications.
28,588 articlesAbbVie’s Q1 2026 results show strong immunology growth even as biosimilar challenges weigh on revenue. Analysts debat...
Amazon faces a pullback even as cloud, ads, and silicon efforts pick up speed. Analysts see roughly 36% upside over t...
A landmark 1964 box set known as The Folk Box is being revisited as a case study on how culture becomes cash. Its leg...
In this in-depth millionaire interview, we chat with a seasoned investor who turned savvy saving into a durable fortu...
Albemarle posted a net loss in 2025 but still paid dividends, underscoring the tension between cash flow and earnings...
Aston Martin plans a major workforce reduction of up to 20%, affecting about 600 roles from a 3,000-employee base. Th...
U.S.-China talks open in Paris as officials prepare for a high-stakes Xi summit. The discussions, led by bessent lead...
Two CoinDCX co-founders were arrested by Indian police amid a fraud probe. The company denies wrongdoing and blames i...
Tapestry reports a record quarter as Coach powerfully taps Gen Z demand with a Goldilocks mix of luxury and accessibi...
SLV has surged about 132% over the past year as inflation fears persist. But the 0.50% annual fee and a 28% tax on co...
Palantir shares moved higher as market chatter tied the AI and national security agenda to politics. Investors weigh ...
Oil markets hold steady as China's quiet demand and reserve releases blunt looming shortages, signaling a near-term c...